Teva Pharma (TEVA) Modestly Lower as Actavis Generics Deal Closing Delayed
Tweet Send to a Friend
Teva Pharma (NYSE: TEVA) is modesty lower Tuesday (-3.4%) after the company announced the closing of its $40.5 billion deal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
